Abstract: The invention is directed to a purified population of mammalian endothelial, muscle, or neural stem cells. The invention further provides methods for isolating such populations of cells; methods for using such populations of cells for treating mammals; methods for making vectors for gene therapy; and methods for carrying out gene therapy with such vectors.
Type:
Grant
Filed:
January 25, 1999
Date of Patent:
February 8, 2005
Assignees:
Cornell Research Foundation, Inc., Sloan-Kettering Institute for Cancer Research, ImClone System Incorporated
Inventors:
Shahin Rafii, Larry Witte, Malcolm A. S. Moore